Literature DB >> 10209523

Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.

M Okawa-Takatsuji1, S Aotsuka, M Fujinami, S Uwatoko, M Kinoshita, M Sumiya.   

Abstract

In order to elucidate the pathogenic role(s) of autoantibodies in connective tissue disease (CTD), we examined whether autoantibodies against U1-ribonucleoprotein (RNP) and double-stranded (ds) DNA can up-regulate ICAM-1, ELAM-1 and class I and II MHC molecule expression on pulmonary artery endothelial cells (HPAEC). ICAM-1, ELAM-1 and class II MHC molecule expression on HPAEC cultured in the presence of anti-U1-RNP-containing and anti-dsDNA-containing IgG from CTD patients was up-regulated significantly in comparison with that on HPAEC cultured with IgG from normal healthy volunteers. Affinity chromatographic enrichment and depletion of the anti-U1-RNP antibody content of anti-U1-RNP-containing IgG confirmed that the anti-U1-RNP antibody did up-regulate ICAM-1, ELAM-1 and class II MHC molecule expression. The finding that an IgG F(ab')2-purified anti-U1-RNP antibody also up-regulated expression of these molecules may indicate that mechanisms other than Fc receptor-mediated stimulation are involved. These in vitro findings suggest that autoantibodies against U1-RNP and dsDNA play important roles in the immunopathological processes leading to the proliferative pulmonary arterial vasculopathy observed in CTD patients with pulmonary hypertension by up-regulating adhesion and class II MHC molecule expression on endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209523      PMCID: PMC1905219          DOI: 10.1046/j.1365-2249.1999.00864.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  High efficiency of endogenous antigen presentation by MHC class II molecules.

Authors:  V Calin-Laurens; F Forquet; S Lombard-Platet; P Bertolino; I Chrétien; M C Trescol-Biémont; D Gerlier; C Rabourdin-Combe
Journal:  Int Immunol       Date:  1992-10       Impact factor: 4.823

Review 2.  Adhesion molecules and their role in inflammation.

Authors:  S Montefort; S T Holgate
Journal:  Respir Med       Date:  1991-03       Impact factor: 3.415

3.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

4.  Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies.

Authors:  M E Luchi; R A Asherson; R G Lahita
Journal:  Arthritis Rheum       Date:  1992-06

5.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  R A Asherson
Journal:  J Rheumatol       Date:  1990-03       Impact factor: 4.666

6.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

Authors:  M P Bevilacqua; S Stengelin; M A Gimbrone; B Seed
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

7.  Pulmonary hypertension in a lupus clinic: experience with twenty-four patients.

Authors:  R A Asherson; T W Higenbottam; A T Dinh Xuan; M A Khamashta; G R Hughes
Journal:  J Rheumatol       Date:  1990-10       Impact factor: 4.666

8.  Antibody penetration of viable human cells. I. Increased penetration of human lymphocytes by anti-RNP IgG.

Authors:  J Ma; G V Chapman; S L Chen; G Melick; R Penny; S N Breit
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

9.  Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.

Authors:  J S Pober; L A Lapierre; A H Stolpen; T A Brock; T A Springer; W Fiers; M P Bevilacqua; D L Mendrick; M A Gimbrone
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

10.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma.

Authors:  C D Wegner; R H Gundel; P Reilly; N Haynes; L G Letts; R Rothlein
Journal:  Science       Date:  1990-01-26       Impact factor: 47.728

View more
  21 in total

1.  Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.

Authors:  María Del Carmen Zamora-Medina; Andrea Hinojosa-Azaola; Carlos A Nuñez-Alvarez; Angel Gabriel Vargas-Ruiz; Juanita Romero-Diaz
Journal:  Clin Rheumatol       Date:  2018-12-04       Impact factor: 2.980

2.  Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration.

Authors:  Giorgio Tasca; Massimiliano Mirabella; Alfredo Berrettini; Mauro Monforte; Pietro Attilio Tonali; Enzo Ricci
Journal:  Neurol Sci       Date:  2010-10-02       Impact factor: 3.307

3.  Pulmonary hypertension in a patient with adult-onset Stills disease.

Authors:  Eisha Mubashir; M Mubashir Ahmed; Samina Hayat; Maureen Heldmann; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-07-27       Impact factor: 2.980

4.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

5.  Oxidative stress is associated with increased pulmonary artery systolic pressure in humans.

Authors:  Nima Ghasemzadeh; Riyaz S Patel; Danny J Eapen; Emir Veledar; Hatem Al Kassem; Pankaj Manocha; Mohamed Khayata; A Maziar Zafari; Laurence Sperling; Dean P Jones; Arshed A Quyyumi
Journal:  Hypertension       Date:  2014-03-10       Impact factor: 10.190

6.  Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.

Authors:  M C Tamby; Y Chanseaud; M Humbert; J Fermanian; P Guilpain; P Garcia-de-la-Peña-Lefebvre; S Brunet; A Servettaz; B Weill; G Simonneau; L Guillevin; M C Boissier; L Mouthon
Journal:  Thorax       Date:  2005-09       Impact factor: 9.139

7.  AAV delivery of tumor necrosis factor-α short hairpin RNA attenuates cold-induced pulmonary hypertension and pulmonary arterial remodeling.

Authors:  Patrick Crosswhite; Kai Chen; Zhongjie Sun
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

Review 8.  Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension.

Authors:  Patrick Crosswhite; Zhongjie Sun
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

Review 9.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

Review 10.  Immune and inflammatory mechanisms in pulmonary arterial hypertension.

Authors:  Hala El Chami; Paul M Hassoun
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.